| | |
| Clinical data | |
|---|---|
| Trade names | Myopridin |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | By mouth, parenteral |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.007.390 |
| Chemical and physical data | |
| Formula | C20H25NO |
| Molar mass | 295.426 g·mol−1 |
| |
| | |
Pridinol, sold under the brand name Myopridin, is a muscle relaxant that is used as an antiparkinsonian and anticholinergic drug. [1] It has also been evaluated for the treatment of muscle related pain. [2]
It was approved for medical use in the UK in May 2020. [3] Pridinol bears structural similarity to another anti-muscarinic drug Diphenidol.